JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 80 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.45 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $40,000 | -54.0% | 13,099 | 0.0% | 0.00% | +200.0% |
| Q1 2022 | $87,000 | -20.2% | 13,099 | 0.0% | 0.00% | -85.7% |
| Q4 2021 | $109,000 | +12.4% | 13,099 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $97,000 | +9.0% | 13,099 | 0.0% | 0.01% | +16.7% |
| Q2 2021 | $89,000 | -34.1% | 13,099 | 0.0% | 0.01% | -40.0% |
| Q1 2021 | $135,000 | -28.9% | 13,099 | -51.7% | 0.01% | -37.5% |
| Q4 2020 | $190,000 | -14.0% | 27,099 | 0.0% | 0.02% | -20.0% |
| Q3 2020 | $221,000 | +18.2% | 27,099 | 0.0% | 0.02% | +17.6% |
| Q2 2020 | $187,000 | +45.0% | 27,099 | 0.0% | 0.02% | -19.0% |
| Q1 2020 | $129,000 | -45.6% | 27,099 | 0.0% | 0.02% | -44.7% |
| Q4 2019 | $237,000 | +163.3% | 27,099 | 0.0% | 0.04% | +192.3% |
| Q3 2019 | $90,000 | -32.8% | 27,099 | 0.0% | 0.01% | -35.0% |
| Q2 2019 | $134,000 | -20.2% | 27,099 | 0.0% | 0.02% | -13.0% |
| Q1 2019 | $168,000 | +84.6% | 27,099 | 0.0% | 0.02% | +64.3% |
| Q4 2018 | $91,000 | -48.3% | 27,099 | 0.0% | 0.01% | -17.6% |
| Q3 2018 | $176,000 | -15.4% | 27,099 | 0.0% | 0.02% | -43.3% |
| Q2 2018 | $208,000 | -65.7% | 27,099 | 0.0% | 0.03% | -64.7% |
| Q1 2018 | $606,000 | – | 27,099 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 10,230,349 | $63,428,000 | 41.36% |
| TRV GP III, LLC | 3,048,780 | $18,902,000 | 9.26% |
| Omega Fund Management, LLC | 1,059,930 | $6,572,000 | 1.39% |
| Alambic Investment Management, L.P. | 50,622 | $314,000 | 0.13% |
| Spark Investment Management LLC | 244,300 | $1,514,000 | 0.07% |
| ALGERT GLOBAL LLC | 14,182 | $88,000 | 0.05% |
| Redmile Group, LLC | 254,590 | $1,578,000 | 0.05% |
| Granahan Investment Management | 125,533 | $778,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 38,602 | $239,000 | 0.02% |
| Frontier Wealth Management LLC | 27,099 | $168,000 | 0.02% |